Clinical Trial 14821

New Bedford, MA 02740


Summary:

Need more help for your OCD (Obsessive Compulsive Disorder)?

When treatment with Anafranil ®, Paxil®, Zoloft®, Luvox®, or Prozac®* just isn’t enough:
There is a new medical research study evaluating a potential additional treatment for OCD patients.

From family to friends to work, Obsessive-Compulsive Disorder can affect every part of your life. For some OCD patients, currently available treatments are enough to help them deal with this disorder. However, many people with OCD may need more than those medications to successfully manage this challenging condition.

If you are one of these patients, you may be interested in learning more about a medical research study of a new investigational medication.


Qualified Participants Must:

• Be at least 18 years of age
• Be diagnosed with OCD
• Have been taking one of the following five medications for at least six weeks prior to this study and at the minimum daily dosage listed: Anafranil® (clomipramine) 150 mg, Luvox® (fluvoxamine) 200 mg, Prozac® (fluoxetine) 40 mg, Paxil® (paroxetine) 40 mg, or Zoloft® (sertraline) 100 mg


Qualified Participants May Receive:

Reimbursement for travel and you will receive additional information on the risks and benefits related to this study if you decide to participate.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.